Cowen Starts Array BioPharma (ARRY) at Outperform
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $12.23 --0%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Join SI Premium – FREE
Cowen initiated coverage on Array BioPharma (NASDAQ: ARRY) with an Outperform rating and a price target of $10.00.
For an analyst ratings summary and ratings history on Array BioPharma click here. For more ratings news on Array BioPharma click here.
Shares of Array BioPharma closed at $5.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EPC Power names Jim Fusaro as CEO
- B.Riley Resumes Outbrain Inc (OB) at Neutral
- Wells Fargo Starts Americold Realty Trust (COLD) at Equal Weight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
